A.R.T. Advisors, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 62 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$196,000
+232.2%
51,024
+339.0%
0.01%
+175.0%
Q1 2019$59,000
-65.5%
11,624
-87.0%
0.00%
-63.6%
Q4 2018$171,000
+108.5%
89,281
+307.2%
0.01%
+175.0%
Q3 2018$82,000
-68.7%
21,926
-80.1%
0.00%
-63.6%
Q1 2018$262,000
-61.8%
109,954
-37.4%
0.01%
-63.3%
Q4 2017$686,000
+251.8%
175,564
+126.8%
0.03%
+200.0%
Q3 2017$195,000
+473.5%
77,407
+523.9%
0.01%
+400.0%
Q2 2017$34,000
-65.7%
12,407
-75.8%
0.00%
-60.0%
Q1 2017$99,000
+50.0%
51,207
-19.1%
0.01%
+25.0%
Q4 2016$66,000
-25.8%
63,300
-49.9%
0.00%0.0%
Q2 2016$89,000
-66.2%
126,289
-44.0%
0.00%
-66.7%
Q1 2016$263,000
+220.7%
225,528
+568.7%
0.01%
+200.0%
Q4 2015$82,000
-79.4%
33,728
-63.4%
0.00%
-71.4%
Q1 2015$398,000
+272.0%
92,100
+155.5%
0.01%
+250.0%
Q4 2014$107,000
-48.1%
36,042
-41.9%
0.00%
-60.0%
Q3 2014$206,00062,0810.01%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 589,883$590,0001.38%
Broadfin Capital, LLC 8,200,000$8,610,0000.96%
Avoro Capital Advisors LLC 1,141,149$1,198,0000.24%
CORRADO ADVISORS, LLC 190,600$200,0000.12%
Baker Brothers Advisors 5,102,153$5,357,0000.05%
KINGDON CAPITAL MANAGEMENT, L.L.C. 756,311$794,0000.04%
Point72 Asset Management, L.P. 2,272,816$2,386,0000.02%
AGRAN LIBBIE 44,000$46,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 10,000$11,0000.01%
KENNEDY CAPITAL MANAGEMENT LLC 233,171$245,0000.00%
View complete list of CATALYST PHARMACEUTICALS INC shareholders